Adverse events attributed to traditional Korean medical practices: 1999–2010
Hyeun-Kyoo Shin a, Soo-Jin Jeong a, Myeong Soo Lee b & Edzard Ernst c
a. Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Republic of Korea.
b. Medical Research Division, Korea Institute of Oriental Medicine, 483 Expo-ro, Yusung-gu, Daejeon 305-811, Republic of Korea.
c. Peninsula Medical School, University of Exeter, Exeter, England.
Correspondence to Myeong Soo Lee (e-mail: firstname.lastname@example.org)
(Submitted: 13 August 2012 – Revised version received: 20 April 2013 – Accepted: 21 April 2013 – Published online: 31 May 2013.)
Bulletin of the World Health Organization 2013;91:569-575. doi: http://dx.doi.org/10.2471/BLT.12.111609 [PDF]
In many countries, medical practices that are categorized as traditional, complementary and/or alternative are common and the focus of current advocacy.1 In 2008, for example, most of the people who lived in Australia (68.9%), China (90%), the Republic of Korea (86%), Malaysia (55.6%) and Singapore (53%) used some form of traditional medicine.2,3 Although some traditional medical practices appear beneficial, many remain untested and there is little relevant monitoring or control. Our knowledge of the adverse effects of such practices is therefore very limited. This hampers the identification of the safest and most effective traditional practices and medicines.1
The adverse effects linked to traditional Korean medicine – as practised in the Democratic People's Republic of Korea and the Republic of Korea – have never been carefully monitored. In 1985, the government of the Republic of Korea passed Ministry of Health and Society Law 85–64, which promoted the development of a national system of pharmacovigilance for tracking adverse drug reactions. Three years later, the Korean Food and Drug Administration established a national system for the voluntary reporting of adverse reactions to drugs and herbal medicines that is currently based on 20 regional pharmacovigilance centres.4,5 Since then, however, very few adverse events attributed to herbal medicines have been recorded by this system. The aim of the present study was to estimate the true incidence of such events in the Republic of Korea, using data from the Food and Drug Administration, another governmental agency (the Consumer Agency) and a nongovernmental organization (the Association of Traditional Korean Medicine).
Publications2–4,6–15 were used to determine the main forms of traditional medicine in use in the Republic of Korea and the corresponding usage rates, as percentages of the national population. Attempts were also made to identify records of any adverse events that occurred in the Republic of Korea between 1999 and 2010 and were attributed to any traditional medical practice. The relevant, published records of the Food and Drug Administration, the Consumer Agency and the Association of Traditional Korean Medicine were surveyed (see Results section of this paper). The Consumer Agency has received and investigated complaints about consumer goods, consumer services, medical services and drugs since 1999. It publishes summary data on adverse events every three years. The members of the Association of Traditional Korean Medicine are all practitioners of traditional medicine. Since 1999, this association has recorded adverse events that appear to be linked to traditional medical practices financed by health insurance companies. Although the association has generally published summary data on such adverse events every three years, it has not published any records for the adverse events it recorded between 2002 and 2004.
Usage of traditional Korean medicine
Traditional Korean medicine includes herbal medicine, acupuncture, moxibustion, cupping therapy and “physical therapies” such as hot pack applications, massage, chiropractic manipulation and infrared irradiation.2,6 In a survey conducted in 2008,7 it was estimated that 86% of the people living in the Republic of Korea had used some form of traditional Korean medicine at least once and that 45.8% had used such medicine in the previous 12 months. However, only 7.2% had ever visited a traditional medicine clinic. Among the people who had received traditional Korean medical treatments, 53.4% had received them for diseases of the musculoskeletal system or connective tissue. The traditional Korean medical treatments received were acupuncture (70.6% of the people who had ever received traditional Korean medicine), a crude herbal formulation (20.8%), physical therapy (4.9%), a refined herbal product (1.3%), cupping therapy (0.9%) and moxibustion (0.6%).7
In 1999 – according to the records of the Republic of Korea’s national health insurance scheme8 – 11 345 practitioners of traditional medicine prescribed or treated patients in 35 877 000 consultations in 6972 traditional medicine clinics in the Republic of Korea. The corresponding values for 2010 – 19 065, 94 634 854 and 12 229, respectively9 – were markedly higher. Currently, acupuncture, moxibustion, cupping therapy, 56 prescription-only herbal medicines, 68 other kinds of herbal medicines and three forms of physical therapy are covered by the national health insurance scheme in the Republic of Korea.2 By 2008, the country’s Food and Drug Administration had licensed 547 crude herbal medicines, all of which were listed in the Korean Pharmacopoeia (n = 165) or the Korean Herbal Pharmacopoeia (n = 382).10,11
There appear to be very few published case reports relating to the adverse effects of traditional Korean medical treatments. In the Republic of Korea in 1979, one boy presented with lead poisoning and another with acute lead encephalopathy; both boys had ingested the same herbal medicine daily for 2 months.12 In the same country in 2006, a problem with sensitivity was reported to have resulted from acupuncture.13 Overall, 1.8%, 2.7% and 12% of the people interviewed in the Republic of Korea in 2005, 2006 and 2007, respectively, reported that they had suffered an adverse event that they associated with some form of traditional Korean medicine.14,15 In government-run surveys conducted in the Republic of Korea in 2008 and 2011, herbal medicines accounted for 8.2% and 3.7% of the adverse events attributed to all forms of traditional Korean medicine, respectively.3,7
Food and Drug Administration
As part of the national system of pharmacovigilance, the Republic of Korea’s Food and Drug Administration collects data on adverse events from pharmaceutical companies, health-care providers, pharmacies and consumers. Only five adverse drug reactions were recorded by the Administration in 1988 but the number of such adverse events recorded each year has since grown, from 148–637 between 1999 and 2002 to 53 854 in 2010.4,16–18
Between 2003 and 2010, the proportion of adverse drug reactions reported to the Administration by pharmaceutical companies decreased from 75.3% to 27.8%, whereas the proportion reported by medical institutions increased from 24.2% to 72.0%. Over the same period, only a few adverse drug reactions were reported to the Administration by pharmacies and consumers (Fig. 1).
Fig. 1. Drug-related adverse events reported to the Food and Drug Administration, Republic of Korea, 2003–2010
Only eight of the 95 449 adverse drug reactions reported to the Administration between 1999 and 2010 – one of those reported in 2007 and seven of those reported in 2008 – were attributed to herbal medicines. All eight were reported by medical institutions.19,20
Between 1999 and 2010, the Republic of Korea’s Consumer Agency received 167 371 complaints – from consumers – about drugs and other medical treatments in general, including 7532 (4.5%) relating to herbal medicines or other forms of traditional Korean medicine. Over the same period, the average annual number of complaints about drugs and other medical treatments increased from 5670 to 27 344, and the average annual number of complaints relating to herbal medicines or other forms of traditional Korean medicine increased from 198 to 859 (Fig. 2).
Fig. 2. Total consumer complaints and consumer complaints related to traditional Korean medical practices, Republic of Korea, 1999–2010
The staff of the Consumer Agency attempt to resolve the complaints they receive through communication with – and arbitration between – the relevant medical or pharmaceutical suppliers and the complainants. However, if the complaint remains unresolved, it is passed to the members of the Consumer Dispute Settlement Commission. Of the 8844 disputes that the members of this commission resolved between 1999 and 2010, 252 (2.8%) were related to traditional Korean medicine (Fig. 3). Over the same period, the percentage of each year’s resolved disputes that were related to traditional Korean medicine – 2.2% (6 of 271) in 1999 and 2.6% (20 of 761) in 2010 – showed little variation.
Fig. 3. Disputes resolved by the Consumer Dispute Settlement Commission, in total and related to traditional Korean medical practices, Republic of Korea, 1999–2010
Between 1999 and 2010, the Consumer Agency recorded sufficient details for 190 complaints relating to traditional Korean medicine to be categorized. These 190 complaints were related to the use of herbal medicines (52.6%), acupuncture/moxibustion (31.1%), physical therapy (9.5%) and other treatments (6.8%). They included 69 cases of worsening symptoms after treatment (36.3%), 47 cases of adverse reactions to herbal medicine (24.7%), 31 cases of apparently ineffective treatment (16.3%), 18 cases of infection (9.5%), five cases of burns (2.6%), four fatalities (2.1%), two cases of pneumothorax (1.1%) and 14 “other” cases. About half (46.8%) of the 47 adverse reactions to herbal medicines involved hepatitis. The herbal medicines associated with hepatitis came from Ephedra sinica, Erigeron canadensis, Pinellia ternata, Xanthium strumarium, Evodia rutaecarpa, Prunus armeniaca, Prunus persica and Sinomenium acutum. Although the causes of the four fatalities were not recorded, acupuncture/moxibustion and cupping therapy were associated with most of the other more serious problems, which included infections, the exacerbation of symptoms, pneumothorax and burns. Of the adverse events reported to the Consumer Agency that were linked to traditional Korean medicine, more than 40% were infections attributed to the mismanagement of acupuncture or cupping therapy.
Over 50% of the adverse events associated with herbal medicines were caused either by misdiagnosis – which often led to the exacerbation of symptoms despite treatment – or by toxic ingredients.
Association of Traditional Korean Medicine
Between 1999 and 2010, the Association published the details of 2246 complaints that had been reported to health insurance companies and attributed to traditional Korean medicine: 330 between 1999 and 2001, 768 between 2005 and 2007 and 1116 between 2008 and 2010. Almost half (46.2%) of these complaints were related to acupuncture/moxibustion. The rest were related to crude herbal formulations (18.3%), physical therapies (11.8%) and “other causes” (i.e. misdiagnoses and injuries from falls; 23.7%). Complaints relating to crude herbal formulations, acupuncture and “other causes” increased over the study period, whereas complaints related to physical therapies decreased (Table 1).
Table 1. Numbers of adverse events attributed to various types of traditional Korean medical practices, Republic of Korea, 1999–2010
The data published by the Association allow the adverse events related to each form of traditional Korean medicine to be identified for just two years within the present study period: 2006 and 2009 (Table 2). For these two years, the adverse event most frequently associated with acupuncture was inflammation, followed by pneumothorax and nerve damage. Minor adverse events reported for these years included skin discoloration, haematoma and a herniated disc. The more serious adverse events reported were the exacerbation of symptoms, termination of pregnancy, oedema, respiratory problems, cerebral infarction and death (one case). The adverse event most commonly associated with moxibustion was a burn. Burns were also reported following infrared irradiation and hot wax therapy. The adverse events most commonly attributed to herbal medicines were hepatitis and hepatosis, followed by stomach ache, vomiting and adverse skin reactions. Of all of the adverse events recorded, 538 were either other injuries that occurred during acupuncture, cupping or physical therapies or the exacerbation of symptoms following misdiagnosis (Table 2) – often the misdiagnosis of a torn muscle ligament as a simple sprain.
Table 2. Per cent distribution of adverse events attributed to various types of traditional Korean medical practices, Republic of Korea, 2006 and 2009
The adverse events associated with traditional Korean medicine are caused either by herbal medicines or by traditional practices such as acupuncture, moxibustion, cupping and physical therapies. Since 2002, when the World Health Organization (WHO) included herbal medicines in its pharmacovigilance scheme,21 each of WHO’s Member States has monitored the use of traditional herbal medicines. In the Republic of Korea, this monitoring is largely based on a national system for detecting adverse reactions to drugs. However, this system, which is run by the Food and Drug Administration, has recorded very few adverse events related to herbal medicines, even though such medicines are commonly used throughout the Republic of Korea.2,7 In China in 2010, in contrast, 95 620 adverse events – including 13 420 severe adverse reactions – were linked to the use of traditional herbal medicines.2,22 It seems clear that the Food and Drug Administration in the Republic of Korea is failing to record most of the adverse events linked to the use of herbal medicine in the country. Between 1999 and 2010, 9624 adverse events linked to the use of traditional Korean medicine were recorded in the Republic of Korea: 7352 by the Consumer Agency, 2264 by the Association of Traditional Korean Medicine and just 8 by the national Food and Drug Administration. Overall, 522 of these events – 100 of those reported to the Consumer Agency, 414 of those reported to the Association of Traditional Korean Medicine and all 8 of those reported to the Food and Drug Administration – were associated with herbal medicines.
The Food and Drug Administration is the Republic of Korea’s “responsible agency” at the Üppsala Monitoring Centre – a WHO collaborating centre for international drug monitoring. Although the Administration appears to have sufficient capabilities for collecting spontaneous reports and for data mining in global pharmacovigilance,5,23 its collection of data on adverse events related to the use of herbal medicines seems poor.
There are at least four reasons why the Administration records so few problems with herbal medicines. First, many of the adverse events recorded by the Administration – 41.3% and 27.8% of those recorded in 2009 and 2010, respectively – are reported by pharmaceutical companies. In 2009, herbal products accounted for just 1.15% of total pharmaceutical production and just 1.3% of the medications prescribed by medical practices or traditional medicine clinics.3,7,24 In 2010, such products accounted for just 0.9% of the health insurance benefits used to pay for traditional Korean medicine.9 The pharmaceutical companies tend to concentrate on non-herbal drugs and, in consequence, report very few adverse effects of herbal formulations.
Second, the 20 medical institutions that form the main source of the reports of adverse events collected by the Food and Drug Administration are all hospitals that only prescribe non-herbal medicines. Most of the institutions that focus on traditional Korean medicine do not currently contribute to the national official pharmacovigilance scheme.
Third, although institutions that focus on traditional Korean medicine can report adverse events to the Food and Drug Administration, most report such events only to the Association of Traditional Korean Medicine. Data collected by the Association are rarely passed on to the Food and Drug Administration.25
Fourth, the consumers of herbal medicines in the Republic of Korea tend to complain about adverse events to the national Consumer Agency and their complaints are seldom passed on to the Food and Drug Administration.
Currently, the national pharmacovigilance system in China involves more regional centres than the corresponding system in the Republic of Korea (34 versus 20).5,22 The Food and Drug Administrations in China and the Republic of Korea – like the Pharmaceuticals and Medical Devices Agency in Japan – are supposed to collect reports of adverse events related to all medicines, including herbal ones.26,27 India, however, has a pharmacovigilance system dedicated to the investigation of traditional ayurvedic drugs. At present, this system is based on eight regional and 30 peripheral centres for pharmacovigilance.28,29 China and the Republic of Korea have not found it necessary to develop such an independent and professional pharmacovigilance system for herbal medicine, presumably because their policy-makers believe that one national system should be able to cover both herbal and non-herbal medicines.
The adverse events linked to the use of traditional Chinese medicines are often idiosyncratic reactions that include allergy, hepatitis, anaphylaxis or liver damage.30,31 Liver problems were found to be the adverse events that were most frequently linked to the use of herbal medicines in the Republic of Korea (present study) and are – globally – the adverse events that are most frequently associated with herbal medicines.32
Like herbal medicines, acupuncture appears to cause many adverse events in the Republic of Korea. Acupuncture is, however, also one of the most common traditional medical practices in the country, and is the treatment that is generally sought for diseases of the musculoskeletal system and connective tissues. In the Republic of Korea, the adverse events associated with acupuncture – with or without moxibustion –were mostly infections, burns and pneumothorax, although nerve damage, skin discoloration, haematoma, a herniated disc and death were also reported. In China, similarly, acupuncture has been associated with pneumothorax, fainting, subarachnoid haemorrhage, infection and death.33 The Republic of Korea’s pharmacovigilance system is not designed to detect the adverse effects of acupuncture – or those of cupping or physical therapies.
Although herbal medicines are associated with many adverse events in the Republic of Korea, very few of these events are recorded by the national system of pharmacovigilance. If adequate protection and advice are to be given to consumers, the underreporting of such events should be addressed as a matter of urgency.
This research was supported by the Korea Institute of Oriental Medicine via the Evidence-based Medicine for Herbal Formulae programme (grant K12031). MSL was supported by the same institute (grants K13281 and K13400).
- WHO traditional medicine strategy, 2002–2005. Geneva: World Health Organization; 2002. Available from: http://whqlibdoc.who.int/hq/2002/who_edm_trm_2002.1.pdf [accessed 15 May 2013].
- The regional strategy for traditional medicine in the Western Pacific (2011–2020). Manila: World Health Organization, Regional Office for the Western Pacific; 2002. Available from: http://www.wpro.who.int/publications/2012/regionalstrategyfortraditionalmedicine_2012.pdf [accessed 15 May 2013].
- A survey on the use of traditional Korean medicine and herbal medicine. Seoul: Ministry of Health and Welfare; 2011. Korean.
- Park BJ. Rationale for developing active drug reaction surveillance system in Korea. J Korean Soc Clin Pharmacol Ther 1994; 2: 105-11.
- Kimura T, Matsushita Y, Yang YH, Choi NK, Park BJ. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan. Pharmacoepidemiol Drug Saf 2011; 20: 1237-45 http://dx.doi.org/10.1002/pds.2244 pmid: 21936017.
- Cheung F. TCM: made in China. Nature 2011; 480: S82-3 http://dx.doi.org/10.1038/480S82a pmid: 22190085.
- A survey on the use of traditional Korean medicine, 2008. Seoul: Ministry of Health and Welfare; 2009. Korean.
- National health insurance statistical yearbook, 1999. Seoul: National Health Insurance Corporation; 2000. Korean.
- National health insurance statistical yearbook, 2010. Seoul: Health Insurance Review Agency; 2011. Korean.
- The Korean pharmacopoeia. 9th ed. Seoul: Food and Drug Administration; 2008. Korean.
- The Korean herbal pharmacopoeia. Seoul: Food and Drug Administration; 2007. Korean.
- Ha SY, Kang KW. Two cases of lead poisoning after taking herb pills. J Korean Pediatr Soc. 1979; 22: 64-70.
- Kim Y, Kim Y, Lee H. The clinical study on 6 cases of patients with side effect caused by acupuncture therapy. J Daejeon Univ Tradit Korean Med Inst. 2006; 15: 47-52.
- Lee JT. Research on intake of Chinese medicine by Koreans. Seoul: Food and Drug Administration; 2007. Korean.
- Lee SD. The study for activation and development of herbal adverse reaction reporting system. Seoul: Food and Drug Administration; 2007. Korean.
- Kim JY, Ha JH, Kim BR, Jang J, Hwang M, Park HJ, et al., et al. Analysis of characteristics about spontaneous reporting – reported in 2008. J Korean Soc Pharmacoepidemiol Risk Manag 2010; 3: 23-31.
- Food and drug statistical yearbook 2011. Seoul: Food and Drug Administration; 2012. Korean.
- Ha JH, Rhou MK, Kim YH, Na HS, Shin HJ, Park HJ. Analysis of adverse event reports received in KFDA for 2009. J Korean Soc Pharmacoepidemiol Risk Manag 2010; 3: 128-36.
- Shin YS, Lee YW, Choi YH, Park B, Jee YK, Choi SK, et al., et al. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers. Pharmacoepidemiol Drug Saf 2009; 18: 910-5 http://dx.doi.org/10.1002/pds.1796 pmid: 19621345.
- Kwon H, Lee SH, Kim SE, Lee JH, Jee YK, Kang HR, et al., et al. Spontaneously reported hepatic adverse drug events in Korea: multicenter study. J Korean Med Sci 2012; 27: 268-73 http://dx.doi.org/10.3346/jkms.2012.27.3.268 pmid: 22379337.
- The importance of pharmacovigilance – safety monitoring of medicinal products. Geneva: World Health Organization; 2002. Available from: http://apps.who.int/medicinedocs/en/d/Js4893e/ [accessed 15 May 2013].
- Zhang L, Yan J, Liu X, Ye Z, Yang X, Meyboom R, et al., et al. Pharmacovigilance practice and risk control of traditional Chinese medicine drugs in China: current status and future perspective. J Ethnopharmacol 2012; 140: 519-25 http://dx.doi.org/10.1016/j.jep.2012.01.058 pmid: 22374080.
- Üppsala Monitoring Centre [Internet]. WHO programme members. Countries participating in the WHO Programme for International Drug Monitoring, with year of joining. Üppsala: ÜMC; 2013. Available from: http://www.who-umc.org/DynPage.aspx?id=100653&mn1=7347&mn2 =7252&mn3=7322&mn4=7442 [accessed 15 May 2013].
- Second 5-year comprehensive plan to foster and develop Korean traditional medicine (2011–2015). Seoul: Ministry of Health and Welfare; 2010. Korean.
- Shaw D, Graeme L, Pierre D, Elizabeth W, Kelvin C. Pharmacovigilance of herbal medicine. J Ethnopharmacol 2012; 140: 513-8 http://dx.doi.org/10.1016/j.jep.2012.01.051 pmid: 22342381.
- Park HL, Lee HS, Shin BC, Liu JP, Shang Q, Yamashita H, et al., et al. Traditional medicine in China, Korea, and Japan: a brief introduction and comparison Evid Based Complement Alternat Med 2012; 2012: 429103 http://dx.doi.org/10.1155/2012/429103 pmid: 23133492.
- Du W, Guo JJ, Jing Y, Li X, Kelton CM. Drug safety surveillance in China and other countries: a review and comparison. Value Health 2008; 11: S130-6 http://dx.doi.org/10.1111/j.1524-4733.2008.00377.x pmid: 18387057.
- Chaudhary A, Singh N, Kumar N. Pharmacovigilance: boon for the safety and efficacy of ayurvedic formulations. J Ayurveda Integr Med 2010; 1: 251-6 http://dx.doi.org/10.4103/0975-9476.74427 pmid: 21731371.
- Baghel M. The national pharmacovigilance program for Ayurveda, Siddha and Unani drugs: current status. Int J Ayurveda Res 2010; 1: 197-8 http://dx.doi.org/10.4103/0974-7788.76779 pmid: 21455443.
- Zeng ZP, Jiang JG. Analysis of the adverse reactions induced by natural product-derived drugs. Br J Pharmacol 2010; 159: 1374-91 http://dx.doi.org/10.1111/j.1476-5381.2010.00645.x pmid: 20233209.
- Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc 2004; 67: 109-16 pmid: 15181962.
- Üppsala Monitoring Centre [Internet]. Classification and monitoring safety of herbal medicines. Üppsala: ÜMC; 2011. Available from: http://www.who-umc.org/graphics/24727.pdf [accessed 15 May 2013].
- Zhang J, Shang H, Gao X, Ernst E. Acupuncture-related adverse events: a systematic review of the Chinese literature. Bull World Health Organ 2010; 88: 915-921C http://dx.doi.org/10.2471/BLT.10.076737 pmid: 21124716.